Fluorescent-guided surgery for early stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new way to find and remove early stomach cancer using a fluorescent dye that makes the cancer glow during surgery. It may help doctors be more precise and preserve more of your stomach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage stomach cancer that has not spread to lymph nodes.
- Your tumor is smaller than 3 centimeters.
- Your tumor is not too close to the stomach opening or the valve at the top of the stomach.
- You are between 20 and 80 years old.
- You are in good general health (able to do normal activities).
- You are scheduled to have laparoscopic or robotic stomach surgery.
- You have not had previous stomach surgery or radiation to the upper abdomen.
- You are not pregnant and have not had other cancers in the last 5 years (except certain skin or thyroid cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This trial tests a combination of two surgical techniques for early-stage stomach cancer. It aims to remove the tumor and check nearby lymph nodes more precisely, which may help guide treatment and reduce side effects.
This trial tests a new image-guided method to find and remove sentinel lymph nodes (the first nodes where cancer might spread) in people with early stomach cancer. The goal is to precisely remove only the affected lymph nodes during surgery, which might mean a less extensive operation and fewer side effects.
This trial tests a surgical technique that combines two types of minimally invasive procedures (laparoscopy and endoscopy) to find and remove the first lymph node that might contain cancer (called the sentinel lymph node) in people with early stomach cancer. The goal is to remove only the necessary lymph nodes, potentially reducing side effects while ensuring the cancer hasn't spread.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
This study tests whether a special fluorescent camera during surgery can help surgeons better operate on resectable (removable) stomach or esophagus cancer. It may help improve how surgery is guided, with the goal of safer and more accurate tumor removal.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.